bioRxivGenomicsPreprint
A new SARS-CoV-2 lineage that shares mutations with known Variants of Concern is rejected by automated sequence repository quality control
Bryan P. ThornlowiD, Angie S. HinrichsiD, Miten JainiD, Namrita DhilloniD, Scott LaiD, Joshua D. KappiD, Ikenna Anigbogu, Molly Cassatt‐JohnstoneiD, Jakob McBroomeiD, Maximilian HaeussleriD, Yatish TurakhiaiD, Terren R. Chang, Hugh E. OlseniD, Jeremy R. SanfordiD, Michael D. StoneiD, Olena M. VaskeiD, Isabel Bjork, Mark A. AkesoniD, Beth ShapiroiD, David H. HaussleriD, Auston Marm KilpatrickiD, Russell B Corbett-DetigiD
- Citations
- 5
Abstract
We report a SARS-CoV-2 lineage that shares N501Y, P681H, and other mutations with known variants of concern, such as B.1.1.7. This lineage, which we refer to as B.1.x (COG-UK sometimes references similar samples as B.1.324.1), is present in at least 20 states across the USA and in at least six countries. However, a large deletion causes the sequence to be automatically rejected from repositories, suggesting that the frequency of this new lineage is underestimated using public data. Recent dynamics based on 339 samples obtained in Santa Cruz County, CA, USA suggest that B.1.x may be increasing in frequency at a rate similar to that of B.1.1.7 in Southern California. At present the functional differences between this variant B.1.x and other circulating SARS-CoV-2 variants are unknown, and further studies on secondary attack rates, viral loads, immune evasion and/or disease severity are needed to determine if it poses a public health concern. Nonetheless, given what is known from well-studied circulating variants of concern, it seems unlikely that the lineage could pose larger concerns for human health than many already globally distributed lineages. Our work highlights a need for rapid turnaround time from sequence generation to submission and improved sequence quality control that removes submission bias. We identify promising paths toward this goal.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil
Carolina Moreira Voloch, Ronaldo da Silva Francisco, … Ana Tereza Ribeiro de Vasconcelos·Journal of VirologyPeer-reviewed·Mar 1, 2021
- Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York
Anthony P. West, Joel O. Wertheim, … Pamela J. Björkman·Nature CommunicationsPeer-reviewed·Aug 9, 2021
- The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
V. Hill, L. du Plessis, … A. Rambaut·bioRxiv·Mar 8, 2022
- Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2
- The rise and fall of SARS-CoV-2 variants and the emergence of competing Omicron lineages
T. R. Wiegand, A. McVey, … B. Wiedenheft·bioRxiv·Feb 9, 2022
- A critical reexamination of recovered SARS-CoV-2 sequencing data
F. Debarre, Z. Hensel·bioRxiv·Feb 15, 2024